News

Featured News

  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • Press Release | March 26, 2020

    First Patient Dosed in EVICTION Trial Evaluating ImCheck’s Lead Anti-Cancer Drug, ICT01: A Novel Gamma Delta T Cell-Activating Immunotherapy

    Read More

    News | March 23, 2020

    First-of-its-kind Engineered Macrophage Cell Therapy Platform Shows Ability to Reduce Tumor Burden and Activate Anti-Tumor Immunity, Improving Overall Survival in Pre-Clinical Cancer Models

    Read More

    Press Release | March 23, 2020

    Pliant Therapeutics Initiates First-in-Human Clinical Trial of PLN-1474 for the Potential Treatment of Liver Fibrosis

    Read More

    Press Release | March 17, 2020

    ImCheck Therapeutics Expands Leadership Team with Appointment of Hans Henrik Chrois Christensen as Chief Financial Officer and Chief Operating Officer

    Read More

    Press Release | March 3, 2020

    Pliant Therapeutics Raises $100 Million in Series C Financing to Advance Therapies for Fibrotic Diseases

    Read More

    News | January 23, 2020

    Business Wire Freenome Announces Encouraging Performance Data for Its Multiomics Blood Test to Detect Early-Stage Colorectal Cancer in a Prospective, Multi-Center Clinical Study

    Read More

    Press Release | January 8, 2020

    Entrada Therapeutics Announces ENTR-501 for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)

    Read More

    Press Release | January 6, 2020

    Carisma Therapeutics Expands Leadership Team

    Read More

    Press Release | December 4, 2019

    ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases

    Read More

    Press Release | November 8, 2019

    Precision BioSciences Announces the Presentation of Initial Clinical Data Supporting the Safety and Clinical Activity of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate, at the American Society of Hematology Annual Meeting

    Read More

    Press Release | November 6, 2019

    Orchard Therapeutics to Present New Registrational Data of Investigational Gene Therapies at the 61st American Society of Hematology Annual Meeting

    Read More

    Press Release | October 28, 2019

    Aptinyx Announces Results of Phase 2 Fibromyalgia Study of NYX-2925 Have Been Selected for Late-Breaking Presentation at the American College of Rheumatology Annual Meeting

    Read More

    News | October 23, 2019

    Novartis bets $80M on Pliant’s preclinical NASH prospect

    Read More

    News | July 19, 2019

    Pyxis Oncology Raises $22 Million Series A

    Read More

    News | July 16, 2019

    Genentech inks its latest discovery deal — this time turning to RNA upstart Skyhawk

    Read More

    News | July 8, 2019

    Fattening the bankroll, Bill Haney adds cancer R&D powerhouse Merck to Skyhawk’s roster of partners out to drug RNA

    Read More

    News | June 10, 2019

    Aptinyx Reports Top-line Data from Phase 2 in Patients with Fibromyalgia

    Read More

    News | June 3, 2019

    Carisma Therapeutics Names Dr. Robert Petit As Chief Scientific Officer

    Read More

    News | May 27, 2019

    Carisma Therapeutics Featured in Nature Biotechnology’s Top Academic Spin-outs 2018

    Read More

    Press Release | May 14, 2019

    Precision BioSciences Appoints Christopher R. Heery, M.D., as Chief Medical Officer

    Read More